SBIR TOPIC: DEVELOPMENT OF DEVICES, DIAGNOSTIC TECHNOLOGIES, OR DIGITAL HEALTH TOOLS FOR TREATMENT, DETECTION, AND DIAGNOSIS OF PEDIATRIC CANCERS AND/OR RARE CANCERSPHASE I CONCEPT TITLE: EVALUATING
Award amount
$506,498Program and phase
SBIR · Phase IAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- COLUMBUS NANOWORKS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DKV6HXMPSJJ5
- Solicitation number
- 75N91024R00019
- Topic code
- Transition PHII
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- EO 14042SBIR TOPIC 425 PHASE I:POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)
- Development of NV-Biosensor platform for quantum-based single molecule detection and its use to detect microRNAs and cortisol as human performance-based biomarkers.
- TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES-MOONSHOT
- Enzymatic attachment of proteins to fluorescent nanodiamond surfaces.
- IGF OT IGF Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging SBIR Topic Phase II
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTPHASE I - DEVELOPMENT OF THERAPEUTIC OR PRE
- DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER
- NOVOMEDIX TRANSITION TO PHASE II - THERAPEUTICS SBIR CONTRACTSBIR PHASE II - ENHANCED OVERALL SURVIVAL IN HIGH-RISK PEDIATRIC SOLID TUMORS USING A NOVEL ORAL SMALL MOLECULE
Research funding history
9 SBIR/STTR records share this UEI (2005–2025). Reported award amounts total $5,431,502. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense